AI assistant
Sending…
MANGOCEUTICALS, INC. — Director's Dealing 2024
Jun 5, 2024
34879_dirs_2024-06-05_42b55ffd-0303-4e89-bcfc-bed062e58f20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANGOCEUTICALS, INC. (MGRX)
CIK: 0001938046
Period of Report: 2024-06-03
Reporting Person: MYERS KENNY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-03 | Common Stock | A | 100000 | — | Acquired | 175000 | Direct |
Footnotes
F1: Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.
More from MANGOCEUTICALS, INC.
Interim / Quarterly Report
2026
May 19
Annual Report
2026
Apr 1
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 19
Delisting Announcement
2026
Feb 6
Capital/Financing Update
2026
Jan 23
Capital/Financing Update
2026
Jan 13
Regulatory Filings
2025
Dec 19